Biogen Inc. buy HC Wainwright
Start price
13.02.25
/
50%
€127.25
Target price
13.02.26
€231.84
Performance (%)
-14.50%
Price
22.07.25
€108.80
Summary
This prediction is currently active. The prediction for Biogen Inc. disappoints with a performance of -14.50%. This prediction currently runs until 13.02.26. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -1.046% | -1.046% |
| iShares Core DAX® | 0.130% | 3.439% |
| iShares Nasdaq 100 | -0.443% | 4.555% |
| iShares Nikkei 225® | 0.350% | 0.350% |
| iShares S&P 500 | -0.203% | 3.724% |
Comments by HC_Wainwright for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at HC Wainwright from $300.00 to $241.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat